Cargando…
The development and application of NRICM101 and NRICM102 for the treatment of COVID-19
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Formosan Medical Association. Published by Elsevier Taiwan LLC.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130323/ https://www.ncbi.nlm.nih.gov/pubmed/37147240 http://dx.doi.org/10.1016/j.jfma.2023.04.015 |
| _version_ | 1785030930338938880 |
|---|---|
| author | Ho, Shung-Tai Tsai, Yun-Ning Su, Yi-Chang |
| author_facet | Ho, Shung-Tai Tsai, Yun-Ning Su, Yi-Chang |
| author_sort | Ho, Shung-Tai |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10130323 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Formosan Medical Association. Published by Elsevier Taiwan LLC. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101303232023-04-26 The development and application of NRICM101 and NRICM102 for the treatment of COVID-19 Ho, Shung-Tai Tsai, Yun-Ning Su, Yi-Chang J Formos Med Assoc Perspectives Formosan Medical Association. Published by Elsevier Taiwan LLC. 2023-07 2023-04-26 /pmc/articles/PMC10130323/ /pubmed/37147240 http://dx.doi.org/10.1016/j.jfma.2023.04.015 Text en © 2023 Formosan Medical Association. Published by Elsevier Taiwan LLC. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Perspectives Ho, Shung-Tai Tsai, Yun-Ning Su, Yi-Chang The development and application of NRICM101 and NRICM102 for the treatment of COVID-19 |
| title | The development and application of NRICM101 and NRICM102 for the treatment of COVID-19 |
| title_full | The development and application of NRICM101 and NRICM102 for the treatment of COVID-19 |
| title_fullStr | The development and application of NRICM101 and NRICM102 for the treatment of COVID-19 |
| title_full_unstemmed | The development and application of NRICM101 and NRICM102 for the treatment of COVID-19 |
| title_short | The development and application of NRICM101 and NRICM102 for the treatment of COVID-19 |
| title_sort | development and application of nricm101 and nricm102 for the treatment of covid-19 |
| topic | Perspectives |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130323/ https://www.ncbi.nlm.nih.gov/pubmed/37147240 http://dx.doi.org/10.1016/j.jfma.2023.04.015 |
| work_keys_str_mv | AT hoshungtai thedevelopmentandapplicationofnricm101andnricm102forthetreatmentofcovid19 AT tsaiyunning thedevelopmentandapplicationofnricm101andnricm102forthetreatmentofcovid19 AT suyichang thedevelopmentandapplicationofnricm101andnricm102forthetreatmentofcovid19 AT hoshungtai developmentandapplicationofnricm101andnricm102forthetreatmentofcovid19 AT tsaiyunning developmentandapplicationofnricm101andnricm102forthetreatmentofcovid19 AT suyichang developmentandapplicationofnricm101andnricm102forthetreatmentofcovid19 |